• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
PSTV

PSTV

Plus Therapeutics, Inc.

NASDAQHealthcareBiotechnologyUS

USD5.42

-0.05 (-0.91%)

Rating:C

Company Profile

CEO

Marc H. Hedrick

IPO Date

2001-07-11

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$5.44

Prev. Close

$5.47

Day Low

$5.28

Day High

$5.45

52W Low

$2.90

52W High

$23.50

Market Cap

$0.01B

Volume

0.10M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

29.2%

Avg Negative

2.9%

Avg Neutral

68.0%

News Feed

Plus Strengthens Commercial RNL Supply Chain with Ten Year Exclusivity Agreement

GlobeNewsWire·7/27/2021·↑ positive

Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/22/2021·↓ negative

Plus Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights

GlobeNewsWire·
7/22/2021
·↓ negative

PSTV Stock Increased Over 10% Intraday: Why It Happened

Pulse2·7/22/2021·↑ positive

Plus Therapeutics Shares Jump As First Patient Treated In Latest Cohort Of Brain Tumor Trial

Benzinga·7/22/2021·↑ positive

Plus Therapeutics to Announce Second Quarter 2021 Financial Results and Host Conference Call on July 22, 2021

GlobeNewsWire·7/15/2021·↑ positive

Plus Therapeutics Announces DSMB Approval to Proceed into Eighth Cohort in ReSPECT™ Glioblastoma Trial

GlobeNewsWire·6/16/2021·↑ positive

Plus Therapeutics Presents at the Sixth Biennial Pediatric Neuro-Oncology Research Conference

GlobeNewsWire·6/10/2021·↑ positive

Plus Therapeutics to Participate in BIO Digital Conference

GlobeNewsWire·6/9/2021·↑ positive

PSTV Stock: From $2.60 To $2.84 (9.23% Increase) Pre-Market Explanation

Pulse2·5/4/2021·↑ positive